Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.

Autor: Geutskens, S B, van der Eb, M M, Plomp, A C, Jonges, L E, Cramer, S J, Ensink, N G, Kuppen, P J K, Hoeben, R C
Zdroj: Gene Therapy. Aug2000, Vol. 7 Issue 16, p1410. 7p.
Databáze: Academic Search Ultimate